| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.6M | — | -17.3% |
| Cost of Revenue | $2.4M | — | -16.9% |
| Gross Profit | $3.2M | — | -17.6% |
| R&D Expense | $2.4M | — | -41.9% |
| SG&A Expense | $3.2M | — | -2.5% |
| Operating Income | -$7.3M | — | +22.3% |
| Pre-tax Income | -$8.2M | — | +11.0% |
| Income Tax | $57K | — | +159.1% |
| Net Income | -$8.2M | — | +10.6% |
| EPS (Basic) | $1.25 | — | +792.9% |
| EPS (Diluted) | $1.25 | — | +792.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $15.0M | -31.3% | -46.2% |
| Short-term Investments | $5.0M | +19.5% | — |
| Accounts Receivable | $2.2M | +3.5% | -30.8% |
| Inventory | $4.2M | -3.3% | -9.7% |
| Current Assets | $28.7M | -18.1% | -25.5% |
| Total Assets | $103.3M | -6.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.0M | — | +9.7% |
| Capital Expenditures | $31K | — | +0.0% |
| Investing Cash Flow | -$826K | — | -2564.5% |
| Financing Cash Flow | $6.8M | — | +0.0% |
| Free Cash Flow | -$6.1M | — | +9.7% |
| -10.7% |
| Current Liabilities | $9.4M | +0.4% | -51.2% |
| Long-term Debt | $30.9M | +0.6% | +63.7% |
| Stockholders' Equity | $62.4M | -8.2% | -15.4% |